MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : BIOTECH
MAXCYTE INC

MaxCyte Inc XNAS: MXCT

Weak Stock

0.80 -0.01 (-1.23%)

75.98% Fall from 52W High

295.8K

XNAS Volume

XNAS 12 Mar, 2026 12:31 PM (EDT)

Board Meeting

The latest board meeting for MaxCyte Inc took place on 11 Mar 2026, for the purpose of MaxCyte Inc Fourth Quarter Earnings Results for 2025 See details

MaxCyte Inc - MXCT - stock price prediction, stock price target, analyst ratings from 7 analysts

MaxCyte Inc has a share price target of US$ 6, revenue growth forecast of -9.6%, and profit growth estimate of -2.4% for FY25, based on top 7 analyst calls.

75.98% Fall from 52W High

MaxCyte Inc - MXCT - stock price prediction, stock price target, analyst ratings from 7 analysts

MaxCyte Inc has a share price target of US$ 6, revenue growth forecast of -9.6%, and profit growth estimate of -2.4% for FY25, based on top 7 analyst calls.

Forecaster Screeners